A phase I study of MicroVAX vaccine in patients with various cancers that have relapsed after initial salvage therapy
Latest Information Update: 18 Aug 2014
At a glance
- Drugs CD40 ligand MUC1 loaded dendritic cell vaccine (Primary)
- Indications Cancer
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors National Cancer Centre (Singapore)
Most Recent Events
- 18 Aug 2014 New trial record